NASDAQ : MLEC

Moolec Science SA — Key statistics

Healthcare · Biotechnology · Cayman Islands

Last price 1.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	2.91M
Enterprise Value	n/a

Dates

Measure	Value
Earnings Date	Dec 15, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	2.08M
Shares Outstanding	2.08M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.45%
Owned by Institutions (%)	0.06%
Float	573,192

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	0.71
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financialefficiency

Measure	Value
Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-28.64%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	2.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Measure	Value
Income Tax	n/a
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	-0.32
52-Week Price Change	-85.03%
50-Day Moving Average	4.70
200-Day Moving Average	7.23
Relative Strength Index (RSI)	20.75
Average Volume (20 Days)	83,713

Shortselling

Measure	Value
Short Interest	5,571
Short Previous Month	2,821
Short % of Shares Out	0.27%
Short % of Float	0.97%
Short Ratio (days to cover)	0.08

Incomestatement

Measure	Value
Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balancesheet

Measure	Value
Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cashflow

Measure	Value
Operating Cash Flow	-5.70M
Capital Expenditures	-402,063
Depreciation & Amortization	1.07M
Net Borrowing	4.79M
Free Cash Flow	-6.10M
FCF Per Share	-$2.93

Margins

Measure	Value
Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	-1.44%
Shareholder Yield	-1.44%
Earnings Yield	n/a
FCF Yield	-209.42%

Analystforecasts

Measure	Value
Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	141.14%
EPS Growth Forecast (3Y)	n/a

Stocksplits

Measure	Value
Last Split Date	Jan 5, 2026
Split Type	Reverse
Split Ratio	1:15

Scores

Measure	Value
Altman Z-Score	n/a
Piotroski F-Score	n/a

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a